Overview

An Open-label, Multicenter Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Status:
Recruiting
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer
Phase:
Phase 1
Details
Lead Sponsor:
Zai Lab (Shanghai) Co., Ltd.
Collaborator:
Zai Lab (US) LLC